Skip to main content

We've Got a Winner

stock analysis
It's IPG.

Income 

Only three of the six stocks have a dividend: NLSN, JCDXF and IPG, and they all look quite good.  Over the past three years, each company has grown their dividend.

Let's look at the measures, the ranks and the final ranking in this category.  The measures are dividend yield, 3 year dividend per share CAGR and 1 year dividend per share growth.


Dividend
Yield		D/S 3 year
CAGR		1 year
D/S growth		SumFinal Rank
JCDXF2%
4		3%
4		8%
5		13

4
NLSN6%
6		5%
5		5%
4		15

5
IPG4%
5		12%
6		17%
6		17

6

IPG has some very nice dividend results.

Value

The value metrics are:
  • price to book
  • price to sales
  • price to earnings (if the company has negative earnings they get a rank of zero)
  • enterprise value to EBITDA.


P/BP/SP/EEV/EBITDASumFinal
Rank
TTD.21
1		11.1
1		103
2		43
1		51
RAMP.03
5		8.1
2		173
1		16
2		102
NLSN.03
4		1.3
4		negative
0		9
5		133
JCDXF.02
6		1.6
3		23
3		13
3		155
IPG.04
3		.8
5		13
4		9
4		166
GRPN.06
2		.7
6		negative
0		7
6		144
All of the companies in the group have what would generally be considered good P/B ratios except for TTD.  The same can be said for P/S but you have to exclude RAMP as well as TTD.  IPG PE ratio is good, JCDXF is acceptable and TTD and RAMP is very expensive.  From an EV/EBITDA perspective, GRPN, IPG and NLSN are attractive.  JCDXF is about average, RAMP is becoming more expensive and TTD is very expensive.

Taking it all together, IPG offers the best value.

Profitability

We'll look at six measures for the profitability factor:
  • gross profit to assets
  • net income margin
  • 5 year average pre-tax return on assets
  • 3 year average return on equity
  • operating income margin
  • free cash flow yield.


GP/ANM5 YR Avg
Pre-Tax ROA		3 Yr Ave
ROE		OMFCFSumRank
TTD.32
4		.18
6		.08
6		.07
4		.22
6		.01
2		286
RAMP.37
5		.03
3		.00
2		-.03
2		.04
2		.02
4		183
NLSN.20
3		-.11
1		.03
3		.01
3		.17
5		.06
5		204
JCDXF.15
2		.07
5		.04
4		.09
5		.08
3		-.01
1		204
IPG.08
1		.07
4		.06
5		.28
6		.10
4		.01
3		23

5
GRPN.76
6		.00
2		-.03
1		-.21
1		.02
1		.06
6		172

TTD had the best profitability results followed by IPG.

What I think


My instinct is to be more defensive given the declining momentum.  I'd like a healthy company with a good dividend and IPG fits the profile.  It's dividend is good.  It's profitability factors are appealing and its good value.  On the downside, its momentum is poor and its quality isn't standout.  However, I could live with those factors.

If You Just Want to Know The Highest Score

Here are the results in tabular form.

Price
Momentum		QualityGrowthIncomeValueProfitabilitySumFinal Rank
TTD646016235
RAMP565023214
NLSN111534151
JCDXF232454203
IPG324665266
GRPN453042182

Look at that, IPG has the highest score.  I like it.  I'm going to watch how it does, maybe take a small position.
Labels:

Comments

Post a Comment

Popular posts from this blog

11 Reasons Why INVRS is Better Than Excel Alone

If you work with your own investment models you likely use excel to build them, but excel isn’t ideal for many reasons and it costs you in other ways.   First, you need good data and it isn’t just lying around in an easy to import format.   You’re either keying it in yourself or paying money for excel downloads.   When you need data from numerous sources – price information, data from different statements and across multiple years - you must merge it from multiple sheets.   It's a n inefficient process which can lead to data corruption. After all this data is collected and merged, models built and tested, the net result is one statistic for one company.   A stand-alone number without context has limited use.   To be meaningful, you need to compare it to similar companies.       This is just a sample of the challenges.  You need software that overcomes these problems and is designed for investment model creation. Surprise!  This software exists,
Post a Comment
Read more

NextEra - Good Dividend in the Renewable Energy Sector

NextEra had good results relative to a group of peers in a factor-based analysis. NextEra has an appealing profitability and income profile. Its price momentum looks decent, with a caveat. Its relatively small size (a small mid-cap) coupled with its industry (renewable energy) further weight the odds that this company could be a strong performer in the future. If you want in on renewable energy, we recommend NextEra. The Analysis Overview I created a portfolio of stocks in the alternative energy sector, looking specifically for companies with a market cap over $1B but less than $4B.  This is a sweet spot that offers strong potential for growth but is also substantial enough not to be too speculative. It's my believe that alternative energy is on the ascendance, where as fossil fuels will inevitably decline (NextEra isn't a pure play in this regard however, natural gas assets are part of its portfolio).  If you share this belief and you want exposure to this ma
Post a Comment
Read more

GlaxoSmithKline Scores High in Quality

I created a portfolio of the top pharmaceutical companies trading in the US and ran a quality of earnings analysis on them.  With the highest possible score being nine, GSK scored the best with seven. Here are the results: Quality of Earnings - Major Pharmaceuticals Here's the balance of the companies in the portfolio.  We can see that AZN was the worst at two. Quality of Earnings - Major Pharmaceuticals 2 Just for laughs, lets see how GSK and AZN have performed from a price perspective. Interestingly, AZN has been outperforming GSK. It'll be interesting to say if this trend will continue or if it will, more correctly I believe, reverse.
Post a Comment
Read more